2 completed. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow AC133 Antigen: new trials by email Literature Review of AC133 Antigen trials Research Report on AC133 Antigen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing Coronary Artery Bypass Grafting Injection of autologous CD133+ stem cells at the time of coronary artery bypass grafting - Heart Failure, Heart Attack | Phase 2 | Completed | University Health Network, Toronto | 20 | 2011-09-01 | 2015-12-02 |
| Bone Marrow Derived AC 133+ and Mono-Nuclear Cells (MNC) Implantation in Myocardial Infarction (MI) Patient AC133, MNC, CONTROL - Myocardial Infarction | Phase 2 / Phase 3 | Completed | Royan Institute | 80 | 2009-05-01 | 2012-12-27 |
Myocardial Infarction (2) · Heart Failure (1)
Royan Institute (1) · University Health Network, Toronto (1)
Canada (1) · Iran (1)
Hamid Gourabi, PhD (1) · Hossein Baharvand, PhD (1) · Masoud Ghassemi, MD (1) · Nasser Aghdami, PhD,MD (1) · Terrence M Yau, MD (1)